sarpogrelate has been researched along with Hypertension in 1 studies
sarpogrelate: structure given in first source
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
Excerpt | Relevance | Reference |
---|---|---|
"Sarpogrelate and quinapril were administered orally for 12 weeks and body and heart weights, systolic blood pressure and the relationships between heart weight and systolic blood pressure were determined." | 1.31 | Effects of chronic administration of sarpogrelate on systolic blood pressure of spontaneously hypertensive rats: comparison with quinapril. ( Hattori, K; Mitomi, A; Nagatomo, T; Nakamura, T; Nakazawa, M; Ohnuki, T; Rashid, M; Setoguchi, Y; Watanabe, K, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Setoguchi, Y | 1 |
Ohnuki, T | 1 |
Rashid, M | 1 |
Nakamura, T | 1 |
Hattori, K | 1 |
Nagatomo, T | 1 |
Watanabe, K | 1 |
Mitomi, A | 1 |
Nakazawa, M | 1 |
1 other study available for sarpogrelate and Hypertension
Article | Year |
---|---|
Effects of chronic administration of sarpogrelate on systolic blood pressure of spontaneously hypertensive rats: comparison with quinapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Hypertension; Isoqui | 2002 |